Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

Running, not enrolling

Conditions studied: Endogenous Cushing's Syndrome

In brief

This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome

Key facts

Study ID

NCT05382156

Run by

RECORDATI GROUP

People needed

206

Starts

2022-06-13

Expected to finish

2027-08-01

Last updated by the study team

2025-11-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent obtained prior to registration of any patient data
• Male or female patients aged 18 years or older with endogenous CS treated with osilodrostat. Treatment with osilodrostat can either be initiated at the first visit of the study or can have been initiated before screening.

You may not qualify if…

• Patients with exogenous CS
• Patients with Pseudo CS
• Patients participating in an interventional clinical trial with an investigational drug.

Where it is running

• Barrow Neurological Institute — Phoenix, Arizona, United States
• Emory University School — Atlanta, Georgia, United States
• Northwestern University — Chicago, Illinois, United States
• Indiana University Schl-med — Indianapolis, Indiana, United States
• St Elizabeth Physicians — Covington, Kentucky, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Mayo Clinic - Rochester — Rochester, Minnesota, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• NYU Grossman School of Medicine — New York, New York, United States
• Memorial Sloan-Kettering Cancer Center (MSKCC) - New York — New York, New York, United States
• Endocrinology Research Associates, Inc. — Columbus, Ohio, United States
• Oregon Health And Science University — Portland, Oregon, United States
• University of Pennsylvania Medical Center — Philadelphia, Pennsylvania, United States
• Froedtert Hospital — Milwaukee, Wisconsin, United States
• Hôpital Haut-Lévêque — Bordeaux, France
• Hospices Civiles de Lyon — Bron, France
• CHU de Grenoble site Nord — Grenoble, France
• Groupement Hospitalier Sud - Hôpital Bicêtre — Le Kremlin-Bicêtre, France
• Hopital Claude Huriez - CHRU Lille — Lille, France
• Hopital de la Conception - APHM — Marseille, France
• Hôpital de Brabois — Nancy, France
• CHU de Nantes-Hopital Laennec — Nantes, France
• Hôpital Cochin — Paris, France
• Hopital Larrey — Toulouse, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.